Spinal Fusion to Boost Global Bone Grafts and Bone Grafts Substitutes Market by 2020 - iHealthcareAnalyst, Inc.

The tremendous increase in the number of orthopedic surgeries performed worldwide with higher preference for knee construction, partial hip replacement, and spinal fusion are the main drivers for the growth of this market.

Maryland Heights, MO, January 18, 2017 --(PR.com)-- The bone graft substitutes segment accounted for the largest share of the global bone grafts and substitutes market in 2015. The tremendous increase in the number of orthopedic surgeries performed worldwide with higher preference for knee construction, partial hip replacement, and spinal fusion are the main drivers for the growth of this market. On an average approximately 450,000 spinal fusions are performed in the U.S. each year. The global bone grafts and bone grafts substitutes market growing at the rate of 5.3% CAGR and estimated to reach USD 3.1 Billion by 2020 due to technological advancement and increase in surgical procedures.

Bone grafting is a surgical procedure that replaces the missing or damaged bone by natural or synthetic bone. There are three major types of bone grafts: autografts, allografts, and bone substitutes. Modern bone grafts, bone grafts substitutes and bioactive factors enhance the natural healing process via osteoinductive, osteoconductive and osteogenic mechanisms in suboptimal conditions. Autologous, allogenic and synthetic substrates contribute to modern fracture care and bone loss. Bone grafts and bone grafts substitutes should be biocompatible, osteoconductive, osteoinductive, structurally similar to bone, easy to use, and cost effective. Autogenous bone grafts contain osteoblast and endosteal osteoprogenitor cells for regenerating the new bone, while limited supply and high donor site morbidity rate are major disadvantages associated with it.

Browse Bone Grafts and Bone Grafts Substitutes Market – Product Types (Demineralized Bone Matrix Allografts, and Bone Graft Substitutes – Bone Morphogenic Proteins and Synthetic Bone Graft Extenders) and Medical Applications (Craniomaxilofacial, Dental, Foot and Ankle, Joint Reconstruction, Long Bone, and Spinal Fusion) 2016-2020 at https://www.ihealthcareanalyst.com/report/bone-grafts-and-substitutes-market/

The global bone grafts and bone grafts substitutes market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on product type (demineralized bone matrix allografts, and bone graft substitutes - bone morphogenic proteins and synthetic bone graft extenders) and its medical applications (craniomaxilofacial, dental, foot and ankle, joint reconstruction, long bone, and spinal fusion), and forecasts growth trends (CAGR% - 2016 to 2020). The global bone grafts and bone grafts substitutes market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global bone grafts and bone grafts substitutes market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global bone grafts and bone grafts substitutes market and included in this report are DePuy Synthes Companies, Zimmer Biomet Holdings, Inc., Baxter International, Inc., Medtronic plc, Stryker Corporation, Wright Medical Technology Inc., AlloSource, NuVasive Inc., and Orthofix Holdings, Inc.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/bone-grafts-and-substitutes-market/

About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States

Email: sales@ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
ContactContact
Categories